Gotham Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Gotham Asset Management's ADPT Position: Q3 2026 in Review
Gotham Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 61% in Q3 2026, buying an estimated $1.12M and bringing the position to 120,258 shares worth $3.48M. The position accounts for 0.01% of the portfolio, ranked #1084.
Gotham Asset Management first reported a position in ADPT in Q2 2022 and has held it in 12 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Gotham Asset Management held 120,258 shares of Adaptive Biotechnologies worth $3.48M as of Q3 2026.
- Gotham Asset Management bought 45,526 Adaptive Biotechnologies shares in Q3 2026, an estimated $1.12M.
- Adaptive Biotechnologies made up 0.01% of Gotham Asset Management's portfolio in Q3 2026, its #1084 holding.
- Gotham Asset Management first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 12 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.